Kaveh Fadakar, Haider Abbas, Sahel Soltani Shahgoli, Sonal Tuli, Afsar Farahani, Marjan Imani Fooladi, Naeeme Taslimi Taleghani, Shaghayegh Esfandiarifard, Ramak Roohipourmoallai, Samaneh Davoudi, Jinghua Chen, Maryam Khoshnood Shariati, Reza Karkhaneh, Nazanin Ebrahimiadib
BACKGROUND: Retinopathy of prematurity (ROP) is a leading cause of irreversible blindness in infants. The Postnatal Growth and ROP (G-ROP) study proposed new screening criteria for ROP. This study aimed to validate the G-ROP screening criteria in a group of Iranian premature infants who were treated in the neonatal intensive care unit (NICU) for at least 40 days. METHODS: In this retrospective study, we extracted the data pertaining to infants admitted to the NICU from January 2020 to December 2021...
2022: Medical Hypothesis, Discovery and Innovation in Ophthalmology